Ultimate magazine theme for WordPress.

BTC
$8,093.65
+1.38%
ETH
$257.07
+2.33%
LTC
$103.66
+6.5%
DASH
$158.55
+0.11%
XMR
$87.48
+1.71%
NXT
$0.03
0%
ETC
$7.37
+1.94%
DOGE
$0.00
+1.2%
ZEC
$73.81
-0.39%
BTS
$0.07
0%
DGB
$0.02
+3.41%
XRP
$0.39
+1.4%
BTCD
$20.33
PPC
$0.41
0%
CRAIG
$0.00
XBS
$2.00
XPY
$0.01
0%
PRC
$0.00
0%
YBC
$1,439.57
0%
DANK
$0.00

Sky High Expectations for This Stock, But Will Growth Continue for Corcept Therapeutics Incorporated (NASDAQ:CORT)

18

Corcept Therapeutics Incorporated (NASDAQ:CORT) shares have been experiencing accelerated earnings and sales growth over the past five years.  Over that time frame the firm has seen earnings growth of 26.90% and sales growth of 89.20%.

Investors are constantly hunting for bargains when picking stocks. There may be times when a particular stock might be flying under the radar, but is usually only a matter of time before someone catches on. Investors might be widening their stock focus to find these undervalued names. This may include small caps, foreign stocks, or stocks that just haven’t become household names. Expanding the scope of interest may help the investor discover areas of future opportunity. Although there are plenty of investors who will stick to the solid, historically steady stocks, there are plenty more that are searching for that next big winner that will give the portfolio a big bump.

While the firm has enjoyed the upward movement, it’s important to look at analyst expectations and where the company is headed from here.  On a consensus basis, analysts are projecting EPS growth of 30.96% for next year and have a $14.50 one year price target on the stock.   The stock recently traded at $10.73.

 Six Fundamental Characteristics of Great Growth Stocks

#6 Huge Mass Markets – The more potential customers there are, the greater the possibility that both the company, and the investment in said company, will be a success. 

#5 Market Dominance/Barriers to Entry – Look for companies who hold patents.  This is great barrier to entry, ensuring no competition.  Look for companies who dominate the market, blowing away the competition, though market dominance can be harder to measure. 

#4 Accelerating Earnings Growth – If a company’s earnings growth rate increases for two consecutive quarters, their growth is accelerating.  Faster growth is better growth, and a company whose earnings growth rate is accelerating is an attractive investment.

#3 Triple-Digit Revenue Growth – Companies growing their revenues at triple-digit rates (100% or better) are usually smaller and less known, making them attractive for buying by institutions. 

#2 High Profit Margins – In recent decades, high-margin stocks have beaten low-margin stocks by a huge amount. 

#1 Top Notch, Innovative Management – All great managers who led their companies to success usually did so by thinking differently.  There is no surefire and quick measurement of management talent.  When you find a top manager, one with a record of prior success and accolades, you should strike.  Top managers usually find a way to overcome obstacles. 

RECENT PERFORMANCE

Let’s take a look at how the stock has been performing recently.  Over the past twelve months, Corcept Therapeutics Incorporated (NASDAQ:CORT)‘s stock was -19.09%.  Over the last week of the month, it was -8.85%, -7.05% over the last quarter, and  -19.21% for the past six months. 

Earnings Per Share (EPS):

EPS is what each share is worth and indicates how much money their sharehoders would acquire if the company was to pay out all of its profits.  Earnings Per Share is computed by dividing the profit total by its share total.  If a company’s profit is $800 million and there are 40 million shares, then the EPS is $20.  EPS is a fantastic way to compare and contrast companies in the same industry.  When a company shows a steady upwards earnings trend, it is a good indicator that the company will dominate companies with a more volatile earnings trend.

Corcept Therapeutics Incorporated (NASDAQ:CORT)’s EPS is 0.60.  Last year, their EPS growth was -54.30% while their EPS growth over the past five years is 26.90%.  Analysts are predicting Corcept Therapeutics Incorporated’s stock to grow 30.96% over the next year and -11.90% over the next five.

Investors might be looking high and low for quality stocks that have fallen out of favor with the investing community. There are plenty of stocks that get continuous coverage from the big media outlets, but there are many others that may be hiding behind the scenes. Conducting thorough stock research can help the investor isolate certain stocks that might be ready for a near-term bounce. With the stock market still trading near record levels, investors will be looking for any opportunity to pounce on shares that might have been left behind for whatever reason.  

- Advertisement -

Just-released report names Cannabis Stock of the Year for 2019! Their last pick has seen a +1,200% return since he released it!

This stock has all of the makings of the next great cannabis stock – early-mover advantage, international exposure and influential partnerships, plus it has a product that is unlike anything else on the market…

You will also receive a free, weekly newsletter to stay on top of the latest industry trends, read analysis on promising cannabis stocks, and more. Click here to receive your Free Report immediately!

Comments